Arctoris

Arctoris operates in the drug discovery sector, leveraging advanced robotics and wet lab automation to generate high-quality, reproducible datasets. The company serves biotech firms, pharmaceutical corporations, and AI-driven drug discovery companies globally. Arctoris developed Ulysses, a unique platform that enhances decision-making in drug discovery by providing data of unprecedented quality, depth, and context. The business model revolves around partnering with clients to accelerate the drug development process, from initial idea to clinical trials, thereby enabling faster delivery of new drugs to patients. Revenue is generated through service contracts and partnerships with companies in the life sciences sector. The company’s team comprises experienced scientists, engineers, and life sciences executives who provide consulting and advisory services to optimize assay cascades and the drug discovery pathway.

Keywords: drug discovery, robotics, wet lab automation, biotech, pharmaceutical, AI drug discovery, Ulysses platform, data quality, assay cascades, clinical trials.